Cross-talk between iron metabolism and diabetes

Diabetes

Volumn 51, Issue 8, 2002, Pages 2348-2354

  Fernández Real, José Manuel ^a   López Bermejo, Abel ^a   Ricart, Wifredo ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; GENETIC PREDISPOSITION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INSULIN RELEASE; IRON METABOLISM; IRON OVERLOAD; METABOLIC REGULATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0036325879     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.8.2348     Document Type: Review

References (85)

1. Major factors in the development of diabetes mellitus in 10,000 men
2. Obesity, very low density lipoproteins and glucose intolerance over fourteen years: The Framingham Study
3. Reciprocal association between insulin sensitivity and the hematocrit in man
4. Hematocrit and risk of NIDDM
5. Relation between iron stores and non-insulin-dependent diabetes in men: Case-control study
6. Diabetes and serum ferritin concentration among U.S. adults
7. New aspects of the insulin resistance syndrome: Impact on haematological parameters
8. Maternal serum ferritin and gestational impaired glucose tolerance
9. Gestational diabetes mellitus in the last trimester: A feature of maternal iron excess?
10. Iron status of the free-living, elderly Framingham Heart Study cohort: An iron-replete population with a high prevalence of elevated iron stores
11. Effect of phlebotomy on plasma glucose and insulin concentrations
12. Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians
13. Blood donations and risk of coronary heart disease in men
14. Response to repeated phlebotomies in patients with non-insulin-dependent diabetes mellitus
15. Blood letting in high-ferritin type 2 diabetes: Effects on insulin sensitivity and β-cell function
16. Coronary microvascular adaptation to myocardial metabolic demand can be restored by inhibition of iron-catalyzed formation of oxygen free radicals in type 2 diabetic patients
17. Iron chelation improves endothelial function in patients with coronary artery disease
18. Iron, lactoferrin and iron regulatory protein activity in the synovium: Relative importance of iron loading and the inflammatory response
19. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men: The Third National Health and Nutrition Examination Survey
20. Body iron stores are associated with serum insulin and blood glucose concentrations
21. Serum ferritin as a component of the insulin resistance syndrome
22. Treatment of resistant hypertension by phlebotomy
23. Therapeutic efficiency of phlebotomy in posttransplant hypertension associated with erythrocytosis
24. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion
25. Factors determining glucose tolerance in patients with thalassemia major
26. Insulin resistance and hyperinsulinemia in homozygous β-thalassemia
27. Large amount of (apo)ferritin in the pancreatic insulin cell and its stimulation by glucose
28. The hemochromatotic human pancreas: A quantitative immunohistochemical and ultrastructural study
29. Prevalence of genetic haemochromatosis among diabetic patients
30. Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus
31. Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene
32. Role of hemochromatosis C 282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy
33. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes
34. Hereditary haemochromatosis mutations (HFE) in patients with type II diabetes mellitus
35. Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM
36. C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes
37. Prevalence of hereditary hemochromatosis in late-onset type 1 diabetes mellitus: A retrospective study
38. Diabetes prevention in BB rats by frequent blood withdrawal started at a young age
39. A new syndrome of liver iron overload with normal transferrin saturation
40. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome
41. Insulin resistance-associated hepatic iron overload
42. Histologic features of the liver in insulin resistance-associated iron overload
43. Liver iron stores in patients with non-insulin-dependent diabetes mellitus
44. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C
45. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane
46. Transcriptional regulation of ferritin messenger ribonucleic acid levels by insulin in cultured rat glioma cells
47. Localization of transferrin receptors and insulin-like growth factor II receptors in vesicles from 3T3-L 1 adipocytes that contain intracellular glucose transporters
48. Hyperinsulinemia in non-cirrhotic haemochromatosis: Impaired hepatic insulin degradation?
49. Insulin resistance and iron overload
50. Clinical consequences of acquired transfusional iron overload in adults
51. Oxidative stress impairs insulin internalization in endothelial cells in vitro
52. Ferritin as a source of iron for oxidative damage
53. Nonenzymatic glycation of transferrin: Decrease of Iron-binding capacity and increase of oxygen radical production
54. Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro
55. Usefulness of biochemical screening of diabetic patients for hemochromatosis
56. Regulation of iron metabolism in HepG2 cells: A possible role for cytokines in the hepatic deposition of iron
57. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women
58. The treatment of haemochromatosis by massive venesection
59. Venesection therapy in idiopatic haemochromatosis: An analysis of 40 treated and 18 untreated patients
60. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of hemochromatosis
61. Deferoxamine therapy in high-ferritin diabetes
62. No effect of deferoxamine therapy on glucose homeostasis and insulin secretion in individuals with NIDDM and elevated serum ferritin
63. High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions
64. Ascorbic acid status and polyol pathway in diabetes
65. Low density lipoprotein oxidation by stimulated neutrophils and ferritin
66. Hemochromatosis associated with endothelial dysfunction: Evidence for the role of iron stores in early atherogenesis
67. Iron overload augments the development of atherosclerotic lesions in rabbits
68. Increased ferritin gene expression in atherosclerotic lesions
69. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice
70. Iron overload diminishes atherosclerosis in apoE-deficient mice
71. Regulators of iron balance in humans
72. Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy
73. Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo
74. Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine
75. Phlebotomy improves vascular dysfunction in high ferritin type 2 diabetes mellitus
76. Effects of an extracellular metal chelator on neurovascular function in diabetic rats
77. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin: Possible mechanisms involved
78. Iron, atherosclerosis, and ischemic heart disease
79. Diabetic nephropathy in hypertransfused patients with β-thalassemia: The role of oxidative stress
80. Lysosomal iron accumulation in diabetic nephropathy
81. Plant-animal subsistence ratios and macronutrient energy estimations in world-wide hunter-gatherer diets
82. The effect of diet on plasma homocysteine concentration in healthy male subjects
83. The effect of dietary protein on in vivo insulin action and liver glycogen repletion
84. Dietary lean red meat and human evolution
85. Mechanisms of iron accumulation in hereditary hemochromatosis